OPA1 and Charcot-Marie-Tooth disease type 2A1: Furthermore, in humans, impaired mitochondrial fusion caused by mutations in Opa1 and Mfn2 are associated with dominant optic atrophy or Charcot-Marie-Tooth disease 2A (CMT2A), respectively.